Insider · CIK 0001323212

Pauwels Eric

Reports to the SEC for 4 companies · WARREN, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001323212

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-10	PTCTPTC THERAPEUTICS, INC.S Sale	CHIEF BUSINESS OFFICER	SSale	−3,711 sh	$75.00	−$278K	73,411
2026-06-10	PTCTPTC THERAPEUTICS, INC.M Exercise/Conversion	CHIEF BUSINESS OFFICER	MExercise/Conversion	+17.6K sh	$18.01	+$316K	90,977
2026-06-10	PTCTPTC THERAPEUTICS, INC.S Sale	CHIEF BUSINESS OFFICER	SSale	−17.6K sh	$75.00	−$1.32M	73,411
2026-06-10	PTCTPTC THERAPEUTICS, INC. · Stock Option (Right to Buy)S Sale	CHIEF BUSINESS OFFICER	SSale	−17.6K sh	—	—	0
2026-02-18	PTCTPTC THERAPEUTICS, INC.S Sale	CHIEF BUSINESS OFFICER	SSale	−3,019 sh	$69.36	−$209K	77,122
2026-01-12	PTCTPTC THERAPEUTICS, INC.S Sale	CHIEF BUSINESS OFFICER	SSale	−1,024 sh	$78.70	−$80.6K	80,141
2026-01-09	PTCTPTC THERAPEUTICS, INC.S Sale	CHIEF BUSINESS OFFICER	SSale	−1,722 sh	$77.41	−$133K	81,165
2026-01-08	PTCTPTC THERAPEUTICS, INC.S Sale	CHIEF BUSINESS OFFICER	SSale	−2,561 sh	$76.42	−$196K	84,928
2026-01-08	PTCTPTC THERAPEUTICS, INC.S Sale	CHIEF BUSINESS OFFICER	SSale	−587 sh	$76.98	−$45.2K	84,341
2026-01-08	PTCTPTC THERAPEUTICS, INC.S Sale	CHIEF BUSINESS OFFICER	SSale	−1,454 sh	$76.45	−$111K	82,887
2026-01-07	PTCTPTC THERAPEUTICS, INC.S Sale	CHIEF BUSINESS OFFICER	SSale	−1,352 sh	$77.48	−$105K	87,489
2026-01-06	PTCTPTC THERAPEUTICS, INC.S Sale	CHIEF BUSINESS OFFICER	SSale	−1,789 sh	$76.95	−$138K	88,841
2026-01-02	PTCTPTC THERAPEUTICS, INC.A Award	CHIEF BUSINESS OFFICER	AAward	+20K sh	—	—	90,630
2026-01-02	PTCTPTC THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	CHIEF BUSINESS OFFICER	AAward	+50K sh	—	—	50,000
2025-12-19	PTCTPTC THERAPEUTICS, INC.M Exercise/Conversion	CHIEF BUSINESS OFFICER	MExercise/Conversion	+138 sh	$66.49	+$9,175.62	70,511
2025-12-19	PTCTPTC THERAPEUTICS, INC.S Sale	CHIEF BUSINESS OFFICER	SSale	−37 sh	$75.66	−$2,799.42	70,474
2025-12-19	PTCTPTC THERAPEUTICS, INC.S Sale	CHIEF BUSINESS OFFICER	SSale	−42 sh	$77.26	−$3,244.92	70,432
2025-12-19	PTCTPTC THERAPEUTICS, INC.S Sale	CHIEF BUSINESS OFFICER	SSale	−59 sh	$78.01	−$4,602.59	70,373
2025-12-19	PTCTPTC THERAPEUTICS, INC.M Exercise/Conversion	CHIEF BUSINESS OFFICER	MExercise/Conversion	+565 sh	$18.01	+$10.2K	70,938
2025-12-19	PTCTPTC THERAPEUTICS, INC.S Sale	CHIEF BUSINESS OFFICER	SSale	−193 sh	$75.45	−$14.6K	70,745
2025-12-19	PTCTPTC THERAPEUTICS, INC.S Sale	CHIEF BUSINESS OFFICER	SSale	−313 sh	$77.73	−$24.3K	70,432
2025-12-19	PTCTPTC THERAPEUTICS, INC.S Sale	CHIEF BUSINESS OFFICER	SSale	−59 sh	$78.43	−$4,627.37	70,373
2025-12-19	PTCTPTC THERAPEUTICS, INC.M Exercise/Conversion	CHIEF BUSINESS OFFICER	MExercise/Conversion	+19.8K sh	$66.49	+$1.32M	90,178
2025-12-19	PTCTPTC THERAPEUTICS, INC.S Sale	CHIEF BUSINESS OFFICER	SSale	−1,500 sh	$75.77	−$114K	88,678
2025-12-19	PTCTPTC THERAPEUTICS, INC.S Sale	CHIEF BUSINESS OFFICER	SSale	−4,537 sh	$76.33	−$346K	84,141
2025-12-19	PTCTPTC THERAPEUTICS, INC.S Sale	CHIEF BUSINESS OFFICER	SSale	−10.5K sh	$77.55	−$818K	73,593
2025-12-19	PTCTPTC THERAPEUTICS, INC.S Sale	CHIEF BUSINESS OFFICER	SSale	−3,220 sh	$78.33	−$252K	70,373
2025-12-19	PTCTPTC THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF BUSINESS OFFICER	MExercise/Conversion	−138 sh	—	—	19,805
2025-12-19	PTCTPTC THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF BUSINESS OFFICER	MExercise/Conversion	−565 sh	—	—	17,566
2025-12-19	PTCTPTC THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF BUSINESS OFFICER	MExercise/Conversion	−19.8K sh	—	—	0
2025-12-18	PTCTPTC THERAPEUTICS, INC.M Exercise/Conversion	CHIEF BUSINESS OFFICER	MExercise/Conversion	+120 sh	$66.49	+$7,978.8	70,493
2025-12-18	PTCTPTC THERAPEUTICS, INC.S Sale	CHIEF BUSINESS OFFICER	SSale	−120 sh	$75.02	−$9,002.4	70,373
2025-12-18	PTCTPTC THERAPEUTICS, INC.M Exercise/Conversion	CHIEF BUSINESS OFFICER	MExercise/Conversion	+251 sh	$18.01	+$4,520.51	70,624
2025-12-18	PTCTPTC THERAPEUTICS, INC.S Sale	CHIEF BUSINESS OFFICER	SSale	−251 sh	$75.00	−$18.8K	70,373
2025-12-18	PTCTPTC THERAPEUTICS, INC.M Exercise/Conversion	CHIEF BUSINESS OFFICER	MExercise/Conversion	+2,831 sh	$66.49	+$188K	73,204
2025-12-18	PTCTPTC THERAPEUTICS, INC.S Sale	CHIEF BUSINESS OFFICER	SSale	−2,831 sh	$75.07	−$213K	70,373
2025-12-18	PTCTPTC THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF BUSINESS OFFICER	MExercise/Conversion	−2,951 sh	—	—	19,943
2025-12-18	PTCTPTC THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF BUSINESS OFFICER	MExercise/Conversion	−251 sh	—	—	18,131
2025-12-17	PTCTPTC THERAPEUTICS, INC.M Exercise/Conversion	CHIEF BUSINESS OFFICER	MExercise/Conversion	+1,245 sh	$66.49	+$82.8K	74,157
2025-12-17	PTCTPTC THERAPEUTICS, INC.S Sale	CHIEF BUSINESS OFFICER	SSale	−1,245 sh	$75.28	−$93.7K	72,912
2025-12-17	PTCTPTC THERAPEUTICS, INC.M Exercise/Conversion	CHIEF BUSINESS OFFICER	MExercise/Conversion	+3,684 sh	$18.01	+$66.3K	74,157
2025-12-17	PTCTPTC THERAPEUTICS, INC.S Sale	CHIEF BUSINESS OFFICER	SSale	−3,584 sh	$75.31	−$270K	70,473
2025-12-17	PTCTPTC THERAPEUTICS, INC.S Sale	CHIEF BUSINESS OFFICER	SSale	−100 sh	$76.00	−$7,600	70,373
2025-12-17	PTCTPTC THERAPEUTICS, INC.M Exercise/Conversion	CHIEF BUSINESS OFFICER	MExercise/Conversion	+35.4K sh	$66.49	+$2.35M	105,734
2025-12-17	PTCTPTC THERAPEUTICS, INC.S Sale	CHIEF BUSINESS OFFICER	SSale	−35.3K sh	$75.44	−$2.66M	70,473
2025-12-17	PTCTPTC THERAPEUTICS, INC.S Sale	CHIEF BUSINESS OFFICER	SSale	−100 sh	$76.00	−$7,600	70,373
2025-12-17	PTCTPTC THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF BUSINESS OFFICER	MExercise/Conversion	−36.6K sh	—	—	22,894
2025-12-17	PTCTPTC THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF BUSINESS OFFICER	MExercise/Conversion	−3,684 sh	—	—	18,382
2025-09-08	PTCTPTC THERAPEUTICS, INC.M Exercise/Conversion	CHIEF BUSINESS OFFICER	MExercise/Conversion	+16.7K sh	$30.86	+$515K	89,610
2025-09-08	PTCTPTC THERAPEUTICS, INC.S Sale	CHIEF BUSINESS OFFICER	SSale	−16.7K sh	$56.94	−$951K	72,912

Recent filings

Accepted (ET)
Jun 124
Pauwels Eric0001323212-26-000010
SEC(opens sec.gov)
Feb 204
Pauwels Eric0001323212-26-000008
SEC(opens sec.gov)
Jan 124
Pauwels Eric0001323212-26-000006
SEC(opens sec.gov)
Jan 84
Pauwels Eric0001323212-26-000004
SEC(opens sec.gov)
Jan 64
Pauwels Eric0001323212-26-000002
SEC(opens sec.gov)
Dec 234
Pauwels Eric0001323212-25-000006
SEC(opens sec.gov)

Companies

Address

C/O PTC THERAPEUTICS, INC. 500 WARREN CORPORATE CENTER DRIVE

WARREN, NJ, 07059